Hrt Financial LP Precision Biosciences Inc Transaction History

Hrt Financial LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$1.15 - $3.34 $767,339 - $2.23 Million	667,252 Added 287.11%	899,651 $1.44 Million
Q1 2022 May 16, 2022	BUY	$2.96 - $7.76 $687,901 - $1.8 Million	232,399 New	232,399 $715,000
Q4 2021 Feb 14, 2022	SELL	$7.4 - $11.66 $176,726 - $278,464	-23,882 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$9.18 - $14.15 $1.35 Million - $2.08 Million	-147,189 Reduced 86.04%	23,882 $275,000
Q2 2021 Aug 16, 2021	BUY	$8.07 - $12.52 $1.38 Million - $2.14 Million	171,071 New	171,071 $2.14 Million

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $539M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.